三氧化二砷对Bel-7402人肝癌细胞株的促凋亡作用-东南大学学报医学版

三氧化二砷对Bel-7402人肝癌细胞株的促凋亡作用

单位：1.南京铁道医学院附属医院,消化科,江苏,南京,210009； 2.中国人民解放军第81医院,肿瘤科,江苏,南京,210002

分类号：R73-36+1

出版年·卷·期（页码）：2000·19·第二期（79-82）

摘要：

目的:研究三氧化二砷(As2O3)在体外是否具有抗肝癌作用,并对其作用机制进行初步探讨.方法:用不同浓度的As2O3处理Bel-7402人肝癌细胞株及L-02正常人肝细胞株,应用四甲基偶氮唑盐比色法(MTT法)观察As2O3对细胞生长的影响,并用电镜、流式细胞仪、DNA电泳等检测方法研究其作用机制.结果:MTT法发现As2O3 0.5～2.0 mg.L-1的浓度均可显著抑制Bel-7402人肝癌细胞株的生长,而对L-02正常人肝细胞株的抑制作用较弱.经As2O3作用后,透射电镜和扫描电镜观察均显示Bel-7402细胞发生了显著的凋亡形态改变;提取细胞DNA行琼脂糖凝胶电泳可见典型的梯形条带;流式细胞仪分析可见有亚G1峰出现,凋亡率呈时间和剂量双重依赖性特点.结论:As2O3在体外可显著抑制肝癌细胞株生长,其作用机制主要是诱导肿瘤细胞凋亡.

Objective The purpose of the experiment was to investigate the anticancer activity of As 2O 3 on liver cancer and its mechanism in vitro .Methods The human hepatocellular carcinoma (HCC) cell line Bel?7402 and the human normal liver cell line L?02 were treated with As 2O 3 in various concentrations for various days,then observed and analysed by 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium bromide(MTT) assay,transmission electron microscopy (TEM),scanning electron microscopy (SEM),flow cytometry (FCM),agarose gel electrophoresis.Results By means of MTT assays, it is found that 0.5～2.0?mg·L 1 As 2O 3 could significantly inhibit the growth of Bel 7402 cell line, but the inhibitation was not obvious for L 02 cells. After 72?h of treatment with 2.0 ?mg·L -1 As 2O 3,under the inspection of TEM, most of the HCC cells displayed typically morphological features of apoptosis. Surface protrusions and blebs were well demonstrated by SEM. The DNA ladder was viewed on the agarose gel electrophoresis. Sub G 1 peaks were recorded in DNA histogram of FCM.The apoptosis rate showed a time and dose dependent feature.Conclusion As 2O 3 has obvious antitumor activity on HCC in vitro .Its mechanism may mainly be inducing liver cancer cells to undergo apoptosis.

参考文献：

[1] 张鹏, 王树叶, 胡龙虎. 三氧化二砷治疗72例急性早幼粒细胞白血病, 1996(2)
[2] 张亭栋. 谈谈癌灵1号注射液对白血病的治疗. 中国中西医结合杂志1998(10)
[3] Chen G Q, Shi X G, Tang W. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL):I.As2O3 exerts dose.dependent dual effects on APL cells, 1997(9)
[4] Shen Z X, Chen G Q, Ni J H. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL):II.Clinical efficacy and pharmacokinetics in relapsed patients, 1997(9)
[5] Look A T. Arsenic and apoptosis in the treatment of acute promyelocytic leukemia. 1998(2). doi:10.1093/jnci/90.2.86
[6] Jeffrey M. Ancient remedy performs new tricks. 1996(2). doi:10.1126/science.273.5275.578
[7] 徐承熊. MTT法测定药物对癌细胞杀伤作用的选择, 1997
[8] Gesi M, Pellegrini A, Soldani P. Ultrastuctural and biochemical evidence of apoptosis induced by a novel inhibitor of protein geranylgeranylation in human MIA PaCa-2 pancreatic cancer cells, 1998(3)
[9] 孟紫强. 砷的分子毒理学研究进展, 1997(5)
[10] 王振义. 开展砷剂治疗白血病的临床和机制研究, 1996(2)
[11] Chen G Q, Zhu J, Shi X G. In vitro studies on celluar and molecular mechanisms of arsenic trioxide(As2O3) in the treatment of acute promyelocytic leukemia:As2O3 induces NB4 cell apoptosis with downregulation of bcl.2 and modulation of PML.RARα/ PML proteins, 1996
[12] 倪建华, 陈国强. 砷的生物学作用及其在临床上的应用前景, 1997(4)
[13] Patel T, Gores G J. Apoptosis and hepatobiliary disease. 1995(6)
[14] Hetts S W. To die or not to die:an overview of apoptosis and its role in disease, 1998(4)
[15] Schulte H R. Apoptosis and hepatocarcinogenesis, 1998(ZK)

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录